Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin's Lymphomas: A Single Center Experience

被引：0
|
作者：
Cai, Qingqing
Chen, Yiming
Zou, Dehui
Badillo, Maria
Zhou, Shouhao
Zhang, Liang
Lopez, Elyse R.
Jiang, Wenqi
Huang, Hui-qiang
Lin, Tongyu
Wang, Michael
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3056.3056
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3056
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase II trial of rituximab as adjuvant therapy to high dose chemotherapy and peripheral blood stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphomas.
    Horwitz, SM
    Negrin, RS
    Stockerl-Goldstein, KE
    Johnston, LJ
    Shizuru, JA
    Stuart, MJ
    Breslin, S
    Blume, KG
    Horning, SJ
    BLOOD, 2001, 98 (11) : 862A - 862A
  • [42] Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
    Heyman, Benjamin
    Rizzieri, David
    Adams, David J.
    De Castro, Carlos
    Diehl, Louis
    Li, Zhiguo
    Moore, Joseph
    Beaven, Anne
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10): : 679 - 686
  • [43] Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed non-Hodgkin and Hodgkin's lymphomas
    Corradini, P
    Dodero, A
    Bregni, M
    Olivieri, A
    Valagussa, P
    Farina, L
    Milani, R
    Scime, R
    Rambaldi, A
    Bonifazi, F
    Patriarca, F
    Locasciulli, A
    Bacigalupo, A
    Gianni, A
    Tarella, C
    BONE MARROW TRANSPLANTATION, 2006, 37 : S47 - S47
  • [44] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY LYMPHOMAS IN CHILDHOOD: SINGLE CENTER EXPERIENCE
    Erbey, F.
    Atay, D.
    Akcay, A.
    Akbiyik, M.
    Ozturk, G.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S317 - S317
  • [45] A Phase II Study of MLN8237 (Alisertib) Alone and in Combination with Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (NHL)
    Maddocks, Kami J.
    Cohen, Jonathon B.
    Christian, Beth
    Flynn, Joseph M.
    Jaglowski, Samantha M.
    Blum, Kristie A.
    BLOOD, 2014, 124 (21)
  • [46] Phase I study of bendamustine combined with rituximab in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Taniwaki, M.
    Ogura, M.
    Matsumoto, Y.
    Uchida, T.
    Ohmachi, K.
    Ando, K.
    Watanabe, T.
    Tobinai, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] How the discovery of rituximab impacted the treatment of B-cell non-Hodgkin's lymphomas
    Mohammed, Raihan
    Milne, Artemis
    Kayani, Kayani
    Ojha, Utkarsh
    JOURNAL OF BLOOD MEDICINE, 2019, 10 : 71 - 84
  • [48] Results of a phase I study of bendamustine in combination with ofatumumab, carboplatin, and etoposide (BOCE) for refractory or relapsed aggressive B-cell non-Hodgkin lymphomas (NHL).
    Gaballa, Sameh
    Palmisiano, Neil David
    Asija, Aakanksha
    Chapman, Andrew E.
    Cloud, Jennifer K.
    Filicko-O'Hara, Joanne E.
    Rose, Lewis J.
    Ramirez, Michael J.
    Alpdogan, Onder
    Flomenberg, Neal
    Pro, Barbara
    Gitelson, Elena
    Weiss, Mark Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] Results of a Phase I/II Study of Bendamustine in Combination with Ofatumumab, Carboplatin and Etoposide (BOCE) for Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas
    Pan, Jonathan
    Ghimire, Sushil
    Zhan, Tingting
    Alpdogan, Onder
    Chapman, Andrew E.
    Carabasi, Matthew
    Martinez-Outschoorn, Ubaldo
    Rose, Lewis J.
    Ramirez, Michael
    Wagner, John L.
    Pro, Barbara
    Weiss, Mark A.
    Flomenberg, Neal
    Porcu, Pierluigi
    Filicko-O'Hara, Joanne
    Gaballa, Sameh
    BLOOD, 2019, 134
  • [50] Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma
    Doocey, RT
    Toze, CL
    Connors, JM
    Nevill, TJ
    Gascoyne, RD
    Barnett, MJ
    Forrest, DL
    Hogge, DE
    Lavoie, JC
    Nantel, SH
    Shepherd, JD
    Sutherland, HJ
    Voss, NJ
    Smith, CA
    Song, KW
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (02) : 223 - 230
12345